NCT00160589View on ClinicalTrials.gov

LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)

PHASE4CompletedINTERVENTIONAL

Enrollment

729

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG

Levocetirizine

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY